Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma.

Auteurs

Lauer UM, Awada A, Postel-Vinay S, Shapiro GI, Thieblemont C, Piha-Paul SA, Paik PK, Shepard DR, Docampo LI, Galot R, Rottey S, Sadrolhefazi B, Marzin K, Musa H, Schöffski P

  • Date de publication

    April 2025

  • Type

    Article

  • Review

    ESMO Open

  • Researcher's name

    AWADA AHMAD HUSSEIN

  • Hôpital

    Institut Jules Bordet

  • Service

    Médecine Oncologique

  • PMID

    40203516

  • DOI

    10.1016/j.esmoop.2025.104499